Pharmana Insights

PHARMANA WIDER VIEW - August 2019 Vol2 Cardiovascular disease (CVD), or heart disease, is an umbrella term that includes all conditions affecting the heart. By 2020, 50 percent of global health care expenditures – about $4 trillion – will be spent on three leading causes of death: cardiovascular diseases, cancer and respiratory diseases. According to…

PHARMANA WIDER VIEW - July 2019 Vol1 The global Alzheimer’s drugs market is going to grow at a CAGR of 1.90% during the period 2017-2021 with Key vendors being Allergan, Eisai Pharmaceuticals, Johnson & Johnson, and Novartis, with other prominent vendors Amgen and Pfizer. Much of the increase will be in developing countries. Already 58%…